Showing results (1061-1070 of 2,563) with videos related to
Sort By:
Pageof 257
Inflammopharmacology|September 26, 2025
In vitro antioxidant activity and in vivo antinociceptive and anti-inflammatory effects of the hydroethanolic extract from leaves of Myrciaria floribunda (H. West ex Willd.) O. Berg in Swiss miceIzabelly Bianca da Silva Santos, Simone Patricia de Freitas Rosa, Wendel César eSilva Pereira, et al.Inflammopharmacology|August 8, 2025
From the Amazon to modern pharmacology: medicinal plants as metabolic and cardiovascular modulators in cardiodiabesityBruno Portela Dias, Henrick Vinícius Prado Dantas, João de Barros Neto, et al.Inflammopharmacology|August 12, 2025
Deciphering the iridoids' boundaries: from soil ecology to anti-inflammatory medicinesM V N L Chaitanya, Hemanth Kumar Manikyam, Neerugatti Dora Babu, et al.Inflammopharmacology|August 14, 2025
Transforming advancing autosomal dominant polycystic kidney disease care: investigating new horizons in treatment and researchKomal Thapa, Heena Khan, Amarjot Kaur, et al.Inflammopharmacology|August 12, 2025
The renin-angiotensin system (RAS) and arthritic diseases: therapeutic potential for RAS inhibitorsYasser H Habib, Mahmoud Khattab, Mennatallah A GowayedInflammopharmacology|August 12, 2025
A systematic review of the role of interleukin inhibitors in lichen planus: therapeutic and paradoxical effectsAmirhossein Heidari, Fatemeh Fathabadi, Kimia Ghanavati, et al.Inflammopharmacology|August 2, 2025
Targeting JAK/STAT signaling pathway by curcumin: implications for spinal cord injury neuroprotectionArman Abroumand Gholami, Fatemeh Tahmasebi, Hossein Haghir, et al.Inflammopharmacology|July 29, 2025
Associations of genetic proxies for non-steroidal anti-inflammatory drugs with increased kidney stone risk: a Mendelian randomization studyJunfa Liu, Kaiyi Dong, Gang Qin, et al.Inflammopharmacology|August 22, 2021
Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trialArash Gholoobi, Vahid Reza Askari, Hossein Naghedinia, et al.Inflammopharmacology|August 10, 2021
Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a r eviewEkta Singh, Gurubasavaraja Swamy Purawarga Matada, Nahid Abbas, et al.Pageof 257